Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Appointments

Set Alert for Appointments

Latest From Appointments

Appointments: IRX Therapeutics, Therachon, Mission Therapeutics and bluebird bio

This week’s roundup includes CEO appointments by Smart Matrix and IRX Therapeutics, with various senior level appointments by companies including Therachon, Mission Therapeutics and bluebird bio.

Appointments BioPharmaceutical

Appointments: Sanofi, Fosun Kite, Milestone, Tocagen, GW Pharma, Hookipa and Bone Therapeutics

This week’s round-up includes the appointment of independent directors by Sanofi’s board of directors, CEO appointments by Fosun Kite Biotechnology and Milestone Pharmaceuticals as well as executive appointments by Tocagen, GW Pharmaceuticals, Bone Therapeutics and Tris Pharma.

Appointments BioPharmaceutical

Appointments: EFPIA, Celgene, AcelRx, PureTech Health, Symbiomix, CRISPR Therapeutics and Achaogen

This latest roundup includes EFPIA's appointment of Nathalie Moll to director general, CEO appointments by YposKesi and Symbiomix Therapeutics, as well as various executive appointments by PureTech Health, Arterial Capital Management and Mitra Biotech.

Appointments

Top Asia Execs To Watch: WuXi NextCode, Fosun Kite, Novartis Japan

The coming of spring has brought a flurry of senior executive moves at companies across Asia including WuXi, Fosun-Kite, Novartis, BGI and Chi-Med.

Appointments Asia Pacific

Appointments: Promethera, HealthTell, Baxter, Alzheon, Gilead, Arena and Ligand

This week's appointment roundup includes senior appointments by Promethera, HealthTell, Alzheon and Gilead Nordic with Baxter International, Therachon and Arena Pharmaceuticals making board appointments.

Appointments

Appointments: Sanofi, Regeneron, Galena, Genmab, Abpro and Myokardia

This week's roundup sees Sanofi appoint Biogen's former SVP of corporate affairs to executive vice president, external affairs. Meanwhile, Galena Biopharma, Abpro, Genmab and Purdue Pharma have all named new executives.

Appointments

Appointments: Avillion, X4 Pharmaceuticals, Summit, Cytovation, Kymab, Ipsen and Sosei

This week's roundup includes the appointments of chief medical officers by both Avillion and X4 Pharmaceuticals and various other senior appointments at Summit Therapeutics, Sosei, Ipsen and Kymab.

Appointments BioPharmaceutical

J.P. Morgan Executive Roundtable, Part 2: Women In Biopharma And The Path Forward

Women fill many roles in biopharma companies, but relatively few are in leadership positions. Executives who spoke with Scrip in a roundtable discussion during the J.P. Morgan Healthcare Conference earlier this month noted the disconnect, but saw some hope for improved gender diversity in the future.

Business Strategies Leadership

Aiming To Lead A Global Operation? Start In China!

Moving from China president to a CEO, from regional Asia head to a global pharmaceutical president, several recent senior executive appointments have people wondering if China is increasingly becoming the new launch pad for high flyers eyeing a global pharma leadership role.

Appointments Strategy

J.P. Morgan Executive Roundtable, Part 1: How To Help Women Move Into The Biopharma C-Suite

Scrip decided to shake things up a bit for its third annual biopharmaceutical executive roundtable held during the J.P. Morgan Healthcare Conference by putting together an all-female panel to talk about the financing and dealmaking landscape as well as the state of women in the industry.

Leadership Business Strategies

Appointments: Adherium, Pharmalink, Cleave Biosciences, Decibel, Minoryx, Oxular and Aelix

This week's roundup includes board appointments by Pharmalink, Oxular, Decibel Therapeutics and executive appointments by various companies including e-Therapeutics, where Amgen's current executive director of corporate development has been appointed CEO, Cleave Biosciences and IXICO.

Appointments BioPharmaceutical

GSK Management Shake Up Ahead Of New CEO Sees Hussain Out, AZ's Miels In

"Succession processes are challenging for everyone involved and, unfortunately, it is rare that all of those involved stay with the company," stated GSK's out-going CEO Andrew Witty, as Abbas Hussain decides to leave the company having lost out on the top job, which went to Emma Walmsley. His successor will be AstraZeneca's Luke Miels.

Companies Commercial
See All
UsernamePublicRestriction

Register